Art
J-GLOBAL ID:200902273928201854   Reference number:07A0052288

p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study

p53発現状況は再発乳癌の内分泌療法が不十分な期間の予測における重要な分子マーカーである:コホート研究
Author (6):
Material:
Volume: 11  Issue:Page: 426-433  Publication year: Dec. 2006 
JST Material Number: L3966A  ISSN: 1341-9625  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0052288&from=J-GLOBAL&jstjournalNo=L3966A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Clinical oncology in general 
Reference (22):
  • CIOCCA, DR. Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine. 2000, 13, 1-10
  • KARDINAL, CG. Hormonal and endocrine therapy of breast cancer. Cancer of the breast. 2002, 693-737
  • RING, AE. Predictors of response to systemic therapy in breast cancer. Forum Genova. 2002, 12, 19-32
  • OSBORNE, CK. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res. 2005, 11, 865-870
  • ARPINO, G. HER2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer : a Southwest Oncology Group study. Clin Cancer Res. 2004, 10, 5670-5676
more...

Return to Previous Page